Anti-Human VE-Statin Reference Antibody (Parsatuzumab, RUO)

Description: Parsatuzumab (BS10428) is a research-grade recombinant antibody targeting NOTCH4-like protein. Produced in mammalian cells with native-like glycosylation.
Highlights:
• Research Grade — For PK/PD studies, assay development, and ADA research.
• Native Glycosylation — Mammalian expression ensures native-like patterns.
Host species: Humanized
Isotype: IgG1-kappa
Species reactivity: Human
Immunogen:
Form: Liquid
Storage instructions:
Storage buffer: 0.01M PBS, pH7.4.
Concentration: 2.18mg/ml
Purity: >95% as determined by SDS-PAGE.
Clonality: Monoclonal
Applications: Research Grade Biosimilar
Target: NOTCH4-likeprotein,Zneu1,MultipleEGF-likedomainsprotein7,Epidermalgrowthfactor-likeprotein7,MEGF7,EGFL7,VE-statin,EGF-likeprotein7,Multipleepidermalgrowthfactor-likedomainsprotein7,Vascularendothelialstatin
Purification: Protein A/G purified from cell culture supernatant.
Endotoxin level: <1EU/mg, determined by LAL gel clotting assay
Expression system: Mammalian Cells
Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names: RG7414,RO5490248,CAS:1312797-14-0
Background: Epidermal growth factor-like protein 7 (EGFL7) is a ~29 kDa protein. Regulates vascular tubulogenesis in vivo. Inhibits platelet-derived growth factor (PDGF)-BB-induced smooth muscle cell migration and promotes endothelial cell adhesion to the extracellular matrix and angiogenesis.
Note: For research use only. Not suitable for clinical or therapeutic use.